These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7576750)

  • 1. Experience with hormonal therapy in advanced epithelial ovarian cancer.
    van der Vange N; Greggi S; Burger CW; Kenemans P; Vermorken JB
    Acta Oncol; 1995; 34(6):813-20. PubMed ID: 7576750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective randomized trial to evaluate different oral dose regimens of medroxyprogesterone acetate in women with advanced breast cancer.
    Clinton OP; Priestman TJ; Latief TN; Earl H; Murphy A; Blackledge GR; Dunn J; Baker P
    Clin Oncol (R Coll Radiol); 1995; 7(4):251-6. PubMed ID: 8845325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can combined androgen blockade provide long-term control or possible cure of localized prostate cancer?
    Labrie F; Candas B; Gomez JL; Cusan L
    Urology; 2002 Jul; 60(1):115-9. PubMed ID: 12100935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized comparison of triptorelin and tamoxifen as treatment of progressive ovarian cancer.
    Jager W; Sauerbrei W; Beck E; Maassen V; Stumpfe M; Meier W; Kuhn W; Janicke F
    Anticancer Res; 1995; 15(6B):2639-42. PubMed ID: 8669839
    [No Abstract]   [Full Text] [Related]  

  • 5. Megestrol acetate in advanced breast carcinoma.
    Espie M
    Oncology; 1994 Oct; 51 Suppl 1():8-12. PubMed ID: 7970508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective randomized study comparing the long-acting gonadotropin-releasing hormone agonist triptorelin, flutamide, and cyproterone acetate, used in combination with an oral contraceptive, in the treatment of hirsutism.
    Pazos F; Escobar-Morreale HF; Balsa J; Sancho JM; Varela C
    Fertil Steril; 1999 Jan; 71(1):122-8. PubMed ID: 9935128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonists of growth hormone-releasing hormone (GH-RH) enhance tumour growth inhibition induced by androgen deprivation in human MDA-Pca-2b prostate cancers.
    Letsch M; Schally AV; Stangelberger A; Groot K; Varga JL
    Eur J Cancer; 2004 Feb; 40(3):436-44. PubMed ID: 14746863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of high dose raloxifene in selected patients with advanced breast carcinoma.
    Gradishar W; Glusman J; Lu Y; Vogel C; Cohen FJ; Sledge GW
    Cancer; 2000 May; 88(9):2047-53. PubMed ID: 10813716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy with flutamide and the LHRH agonist [D-Trp6, des-Gly-NH(2)10]LHRH ethylamide in stage C prostatic carcinoma.
    Dupont A; Cusan L; Gomez JL; Koutsilieris M; Suburu R; Emond J; Labrie F
    Br J Urol; 1993 Nov; 72(5 Pt 1):629-34. PubMed ID: 10071551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial of megestrol acetate vs. megestrol acetate/tamoxifen for the management of progressive or recurrent epithelial ovarian carcinoma.
    Belinson JL; McClure M; Badger G
    Gynecol Oncol; 1987 Oct; 28(2):151-5. PubMed ID: 3311923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial.
    Del Mastro L; Boni L; Michelotti A; Gamucci T; Olmeo N; Gori S; Giordano M; Garrone O; Pronzato P; Bighin C; Levaggi A; Giraudi S; Cresti N; Magnolfi E; Scotto T; Vecchio C; Venturini M
    JAMA; 2011 Jul; 306(3):269-76. PubMed ID: 21771987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newer methods of hormonal therapy for prostate cancer.
    Soloway MS
    Urology; 1984 Nov; 24(5 Suppl):30-8. PubMed ID: 6437034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status of high-dose progestins in breast cancer.
    Abrams JS; Parnes H; Aisner J
    Semin Oncol; 1990 Dec; 17(6 Suppl 9):68-72. PubMed ID: 2148027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Megestrol acetate: first-line therapy for advanced breast cancer.
    Johnson PA; Bonomi PD; Anderson KM; Wolter JM; Economou SG
    Semin Oncol; 1986 Dec; 13(4 Suppl 4):15-9. PubMed ID: 3798124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind, randomized study of primary hormonal treatment of stage D2 prostate carcinoma: flutamide versus diethylstilbestrol.
    Chang A; Yeap B; Davis T; Blum R; Hahn R; Khanna O; Fisher H; Rosenthal J; Witte R; Schinella R; Trump D
    J Clin Oncol; 1996 Aug; 14(8):2250-7. PubMed ID: 8708714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose megestrol acetate therapy of ovarian carcinoma: a phase II study by the Northern California Oncology Group.
    Sikic BI; Scudder SA; Ballon SC; Soriero OM; Christman JE; Suey L; Ehsan MN; Brandt AE; Evans TL
    Semin Oncol; 1986 Dec; 13(4 Suppl 4):26-32. PubMed ID: 3099393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced ovarian carcinoma: response to antiestrogen therapy.
    Myers AM; Moore GE; Major FJ
    Cancer; 1981 Dec; 48(11):2368-70. PubMed ID: 7296486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of hormonal manipulation in lymphangioleiomyomatosis. A 20-year-experience in 36 patients.
    Schiavina M; Contini P; Fabiani A; Cinelli F; Di Scioscio V; Zompatori M; Campidelli C; Pileri SA
    Sarcoidosis Vasc Diffuse Lung Dis; 2007 Mar; 24(1):39-50. PubMed ID: 18069418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology Association.
    Muss HB; Wells HB; Paschold EH; Black WR; Cooper MR; Capizzi RL; Christian R; Cruz JM; Jackson DV; Powell BL
    J Clin Oncol; 1988 Jul; 6(7):1098-106. PubMed ID: 3292710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parenteral estrogen versus total androgen ablation in the treatment of advanced prostate carcinoma: effects on overall survival and cardiovascular mortality. The Scandinavian Prostatic Cancer Group (SPCG)-5 Trial Study.
    Hedlund PO; Henriksson P
    Urology; 2000 Mar; 55(3):328-33. PubMed ID: 10699602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.